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Summary
Objective: To ascertain, using speciﬁc inhibitors, the potential role of calcium-related signal transduction pathways in the mechanism of car-
tilage matrix protein gene induction and metalloproteinase gene suppression by capacitively coupled electric ﬁelds.
Methods: Articular chondrocytes were isolated from adult bovine patellae and cultured in high density for 7 days. To study matrix protein ex-
pression, cells cultured in the absence or presence of speciﬁc calcium pathway inhibitors were exposed to a capacitively coupled electrical
ﬁeld (60 kHz, 20 mV/cm): for aggrecan 1 h at 50% duty cycle and for type II collagen 6 h at 8.3% duty cycle. To study metalloproteinase ex-
pression in the presence of interleukin 1 beta (IL-1b), cells were cultured as above but exposed for only 30 min to a 100% duty cycle signal. At
harvest, total mRNA was isolated and aggrecan, type II collagen, matrix metalloproteinase (MMP-1, -3 and -13) and aggrecanase [a disinte-
grin and metalloproteinase with thrombospondin repeats (ADAMTS-4 and -5)] mRNA expression were measured by quantitative real-time
polymerase chain reaction (qPCR).
Results: (1) In the absence of inhibitors, appropriate electrical stimulation induces a 3e4-fold up-regulation of both aggrecan and type II col-
lagen mRNA and a 3.7e9.6-fold down-regulation of IL-1b-induced metalloproteinases; (2) the presence of inhibitors alone does not affect any
target mRNA levels; (3) inhibitors of intracellular calcium regulation and inositol 1,4,5-triphosphate (IP3) formation [8-(diethylamino)octyl-3,4,5,-
trimethoxybenzoate hydrochloride (TMB-8) and neomycin, respectively] have no effect on regulation of target mRNA levels by electrical stim-
ulation; and (4) inhibitors of voltage-gated calcium channels (verapamil), calmodulin activation (N-(6-aminohexyl)-5-chloro-1-naphthalenesul-
fonamide hydrochloride, W-7), calcineurin activity (cyclosporin A), phospholipase C activity (bromophenacyl bromide, BPB) and prostaglandin
E2 (PGE2) synthesis (indomethacin) completely inhibit the effects of electrical stimulation.
Conclusions: The results are consistent with the effects of electrical stimulation involving a pathway of extracellular Ca2þ inﬂux via voltage-
gated calcium channels rather than from intracellular Ca2þ repositories; and with downstream roles for calmodulin, calcineurin and nuclear
factor of activated T-cells (NF-AT) rather than for phospholipase C and IP3.
ª 2008 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
Key words: Articular chondrocytes, Electrical stimulation, Signal transduction, Collagen, Aggrecan, Metalloproteinase, Calcium.Introduction
Osteoarthritis (OA), a debilitating disease affecting approx-
imately 21 million Americans, is chieﬂy characterized by
a progressive loss of the articular surface of many joints in-
cluding those of the hips, knees, lower back, neck, thumbs
and the distal ends of the ﬁngers1. Although the precise eti-
ology of OA is still unknown, it is clear that the deﬁning car-
tilage matrix destruction involves the active participation of
the resident chondrocytes2 and members of the MMP (ma-
trix metalloproteinase) and ADAMTS (a disintegrin and1Investigation performed at the McKay Laboratory of Orthopaedic
Surgery Research, University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania.
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397metalloproteinase with thrombospondin repeats) families
of proteases3.
Chondrocytes in articular cartilage exist in a relatively iso-
lated environment since this tissue lacks blood vessels, lym-
phatic vessels and nerves. As a result, it is the role of
mechanical forces during weight bearing and joint movement
to provide the synovial ﬂuid ﬂow necessary for chondrocyte
nutrition and maintenance. The fact that the cartilage matrix
is rich in ﬁxed ionized macromolecules, this ﬂuid ﬂow results
in strain- and diffusion-generated electric potentials that are
important in cartilage homeostasis4e7. Changes to the carti-
lage matrix that occur in OA result in a loss of the ﬁxed ionic
environment and presumably lead to a disruption of the phys-
iologic electrical ﬁelds required for normal matrix mainte-
nance. One modality to restore this important signaling
system is the provision of a capacitively coupled electric ﬁeld.
The term ‘‘capacitive’’ is used since the arrangement of elec-
trodes and targeted cells/tissue resembles a capacitor (an
electrical element used to temporarily store a charge) with
the tissue/cells in their dielectric medium placed between
a pair of electrodes. Stimulation occurs by a transfer of elec-
trical energy from the capacitor to the targeted tissue (cou-
pling) via the induced electric ﬁeld8. A schematic diagram
0 87
Days of Incubation
Treatment Period
Aggrecan
Type II collagen
Metalloproteinases
0 2
0 2
0 2 2.5 24
3 6
8
± IL, ± Inhibitors 
harvest
Duration (h)
Duration (h)
Duration (h)
harvest
harvest
398 J. Xu et al.: Signal transduction in electrically stimulated chondrocytesof the in vitro stimulation apparatus is shown in Brighton
et al.9.
Recent results from our laboratory have shown that artic-
ular cartilage chondrocytes or explants (from normal adult
bovine or osteoarthritic human cartilage) exposed in vitro
to capacitively coupled electric ﬁelds respond by increasing
aggrecan and type II collagen gene and protein expres-
sion9e11, and by suppressing metalloproteinase gene ex-
pression9. This response pattern would be appropriate for
the treatment of OA in which loss of matrix (especially ag-
grecan) and increase of metalloproteinase activity are pa-
thognomonic12,13. Although it appears that this modality
might be suitable, the mechanism(s) by which capacitive
coupling leads to gene regulation in chondrocytes remains
to be determined.
In a previous study using known signal transduction path-
way inhibitors in vitro, it was concluded that the transduction
of a capacitively coupled electrical signal regulating bone
cell proliferation is via Ca2þ translocation through voltage-
gated calcium channels (inhibited by verapamil) resulting in
elevated intracellular Ca2þ levels and a concomitant increase
in phospholipase A2 (PLA2) activity (blocked by bromophe-
nacyl bromide, BPB). The latter increase leads to cyclooxyge-
nase (COX)-dependent prostaglandin E2 (PGE2) synthesis
(blocked by indomethacin), and the former increase results
in activation of calmodulin (blocked by N-(6-aminohexyl)-5-
chloro-1-naphthalenesulfonamide hydrochloride, W-7)14,15.
Articular chondrocytes are also known to possess volt-
age-gated calcium channels16. Moreover, using a speciﬁc
voltage-gated calcium channel inhibitor (PD-0200347), Boil-
eau et al. have shown that chondrocyte metalloproteinase
expression is inhibited, and that development of OA is con-
sequently retarded in a canine disease model17,18. Recent
data have also demonstrated that elevated intracellular
Ca2þ in chondrocytes can induce chondrogenesis through
a calcineurin/NF-AT (nuclear factor of activated T-cells) sig-
naling pathway19.
The goal of the experiments described in this in vitro study
was to ascertain, using speciﬁc inhibitors, the potential role of
calcium-related signal transduction pathways in the mecha-
nism of cartilage matrix protein induction and metalloprotei-
nase suppression by capacitively coupled electric ﬁelds in
adult bovine articular chondrocytes. The data show that the
effects of capacitively coupled electrical stimulation are
blocked by verapamil, N-(6-aminohexyl)-5-chloro-1-naph-
thalenesulfonamide hydrochloride (W-7), cyclosporin A,
BPBand indomethacin; but not by neomycin or 8-(diethylami-
no)octyl-3,4,5,-trimethoxybenzoate hydrochloride (TMB-8).
This is consistent with a pathway involving an extracellu-
lar Ca2þ inﬂux through voltage-gated calcium channels
rather than from intracellular Ca2þ repositories; and with
roles for calmodulin, calcineurin and NF-AT rather than
for phospholipase C and inositol 1,4,5-triphosphate (IP3).± Electricity 
Fig. 1. Experimental design showing the protocol followed for all ex-Materials and methodsperiments. All cultures were grown for 7 days and were treated on
the 8th day. For aggrecan and collagen experiments, cells were in-CHONDROCYTE ISOLATION AND CULTUREcubated in the absence or presence of signal transduction pathway
inhibitors for 2 h prior to initiation of electrical stimulation at 60 kHz
and 20 mV/cm (1 h at 50% duty cycle for aggrecan, gray box, and
6 h at 8.3% duty cycle for type II collagen, white box); samples were
harvested 4 h and 6 h after initiation of electrical stimulation, re-
spectively. For metalloproteinase experiments, cells were incu-
bated in the absence or presence of signal transduction pathway
inhibitors and/or IL-1b for 2 h prior to initiation of electrical stimula-
tion (30 min at 100% duty cycle, black box); samples were har-
vested 22 h after initiation of electrical stimulation.Chondrocytes were isolated by proteolytic digestion of cartilage slices from
the articular surface of freshly collected adult (18e30 months) bovine patellas
as described previously10. Brieﬂy, under aseptic conditions cartilage slices
were minced and incubated sequentially at 37C with 0.04% (w/v) bovine tes-
ticular hyaluronidase (Sigma Chemical Corp., St Louis, MO) in 150 ml of cal-
cium- and magnesium-free (CMF) Hanks’ balanced salt solution (Life
Technologies, Inc.) for 90 min followed by 0.2% trypsin (w/v) (Life Technolo-
gies, Inc., Rockville, MD) in the same medium for 30 min. The undigested
pieces were allowed to settle before being resuspended in 0.2% bacterial col-
lagenase (Type I-S, Sigma) in 150 ml of a-MEM (Life Technologies, Inc.) con-
taining 5% fetal bovine serum (FBS) and digested overnight at 37C. Theresulting suspension was centrifuged at 500e1000 g, the cell pellet washed
three times in serum-free medium and resuspended in serum-containing
a-MEM. Aliquots were stained with Trypan Blue for hemocytometer cell count-
ing and viability assessment. We routinely obtained w50 106 cells/g wet
weight cartilage with a viability>95%. Chondrocytes were plated at a concen-
tration of 500,000 viable cells/cm2 onto the glass coverslip portion of specially
modiﬁed Cooper dishes, covered with a normal Petri dish top and incubated
for 7 days in medium supplemented with 1% FBS and 50 mg sodium ascor-
bate/ml. Under these conditions, histologic examination showed individual
chondrocytes or pairs of chondrocytes embedded in a toluidine blue-stained
matrix layer 2e3 cells thick (unpublished results cited in Ref. 10). All experi-
ments were performed using primary cultures10,20.CAPACITIVELY COUPLED ELECTRICAL STIMULATIONFigure 1 shows a schematic representation of the experimental design.
On the day of stimulation, the medium was changed and appropriate addi-
tions (cytokine and/or inhibitor) were made to the cultures 2 h prior to initia-
tion of electrical stimulation. All cultures that were used to assess
metalloproteinase expression were grown in either the absence or presence
of 10 ng/ml interleukin 1 beta (IL-1b, R&D Systems, Minneapolis, MN), and
all cultures used to assess the signal transduction pathways were incubated
in the absence or presence of various speciﬁc inhibitors including verapamil
(Sigma, St. Louis, MO) to block voltage-gated calcium channels21,22, neomy-
cin (Pharma-Tek, Huntington, NY) to block phospholipase C-mediated hy-
drolysis of phosphatidylinositol 4,5-bisphosphate (PIP2)
23, 40-BPB (Sigma)
to block PLA2 activity
24, TMB-8 (Sigma) to block calcium release from
intracellular stores25, indomethacin (Sigma) to block prostaglandin (PG)
synthesis from arachidonic acid (AA) via COXs26,27, N-(6-aminohexyl)-5-
chloro-1-naphthalenesulfonamide hydrochloride (W-7, Sigma) to antagonize
calmodulin interactions28 and cyclosporin A (Sigma) to block calmodulin-
dependent calcineurin-mediated dephosphorylation of the IP3 receptor as
well as signaling by NF-AT29,30. Figure 2 shows a schematic diagram of
the pathway steps known to be inhibited by these compounds. The concen-
trations of inhibitors used in this study were 40 mM verapamil, 30 mM neomy-
cin, 25 mM BPB, 150 mM TMB-8, 20 mg/ml indomethacin, 4 mM W-7 and
40 mg/ml cyclosporin A. In separate experiments (not shown), these concen-
trations were determined to be the highest that were not cytotoxic to adult bo-
vine articular chondrocytes. Although we cannot rule out other non-speciﬁc
effects of these inhibitors, it is important to note that in the experiments per-
formed, the mRNA levels of the cartilage matrix molecules measured were
virtually unchanged in the presence of the various inhibitors at the concentra-
tions used (compare white bars in Figs. 3e5).
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Fig. 2. Schematic diagram of relevant calcium signal transduction
pathways showing the steps inhibited (indicated by a red ) by
the speciﬁc compounds tested. The main pathway of interest in-
volves the opening of voltage-gated calcium channels (blocked
by verapamil) by electrical stimulation, allowing the entry of extra-
cellular Ca2þ resulting in elevated cytoplasmic Ca2þ levels. This re-
sults in activation of calmodulin (blocked by W-7) and the
subsequent activation of calcineurin which dephosphorylates NF-
AT (blocked by cyclosporin A). NF-AT then translocates to the nu-
cleus where it acts in conjunction with other associated proteins as
transcription factors. Another calcium-related pathway involves the
conversion of PIP2 to IP3 by the action of phospholipase C (blocked
by neomycin) and the IP3-induced release of intracellular Ca
2þ
stores to the cytoplasm (blocked by cyclosporin A and TMB-8).
An increase in intracellular Ca2þ can also increase in PLA2 activity
(blocked by BPB) leading to PGE2 synthesis (blocked by indometh-
acin). IP3R¼ inositol 1,4,5-triphosphate receptor, TF¼ any one or
more generic transcription factors associated with NF-AT (Diagram
adapted from Ref. 15).
399Osteoarthritis and Cartilage Vol. 17, No. 3The unique in vitro capacitively coupled electrical stimulation used in this
study has been described in detail elsewhere9,11,15,20. Electrodes are placed
in contact with quartz coverslips on the top and bottom of the culture dish and
a uniform ﬁeld is generated in the medium and cells between the electrodes.
To study aggrecan expression, a capacitively coupled 20 mV/cm electric ﬁeld
at a frequency of 60 kHz was applied for 1 h at a 50% duty cycle (1 min on,
1 min off) and samples were harvested 4 h after initiation of stimulation; to
study type II collagen expression, a capacitively coupled 20 mV/cm electric
ﬁeld at a frequency of 60 kHz was applied for 6 h at an 8.3% duty cycle
(1 min on, 11 min off) and samples were harvested 6 h after initiation of stim-
ulation; to study metalloproteinase expression, a capacitively coupled 20 mV/
cm electric ﬁeld at a frequency of 60 kHz was applied continuously (100% duty
cycle) for 30 min and samples were harvested 22 h after initiation of stimula-
tion; these experimental conditions were determined in previous studies9,10.
Electrical control cultures were treated identically except that electrodes
were not connected. At the end of the experiment, each culture was harvested
in 2 ml Trizol Reagent (Life Technologies, Inc., Rockville, MD) and frozen at
80C prior to RNA isolation and analysis as described below.RNA ISOLATION AND QUANTITATIVE REAL-TIME
POLYMERASE CHAIN REACTION (qPCR)Total RNAwas isolated and characterized as described previously31. Brieﬂy,
RNAwas puriﬁedusingelements of a one-stepmethod combinedwith a columnpuriﬁcation step (RNeasy Total RNA Kit, Qiagen, Inc., Valencia, CA) and sub-
sequently digested with DNase I (DNA-free kit, Ambion, Austin, TX)32.
Reverse transcription (RT) followed by qPCR (two-step) was performed
as described previously10,31. Oligonucleotide primers for bovine aggrecan,
type II collagen, MMP-1, -3 and -13, aggrecanase-1 and -2 (ADAMTS-4
and -5) and glyceraldehyde phosphate dehydrogenase (GAPDH, reference
gene) were based on database sequences and were designed using Primer-
Express 2.0 (Applied Biosystems, Foster City, CA) software. To further en-
sure that the qPCR signal was generated from cDNA (as opposed to
genomic DNA), primer pairs were placed in different exons or across an in-
tron/exon boundary wherever possible. All primer pairs had melting temper-
atures of 58e60C and yielded products 73e127 bp (Table I); primers used
for bovine aggrecan, type II collagen and GAPDH have been described pre-
viously10. To verify that the expected products with respect to size and homo-
geneity were obtained, melting proﬁles of qPCR products were acquired after
completion of the ampliﬁcation process (Applied Biosystems), and aliquots
were analyzed by electrophoresis on 2% agarose gels. Relative quantiﬁca-
tion of mRNA expression for each of the target genes was accomplished
by normalizing to a housekeeping gene as described previously; GAPDH
was chosen because its expression did not vary appreciably with electrical
stimulation and/or inhibitor addition in these cells10. For each experiment,
corrected DCT values were obtained for control (untreated and unstimulated)
cultures and experimental (treated and/or stimulated) cultures whose RNA
was isolated at the same time, reverse transcribed and analyzed by
qPCR; for comparison within and between experiments, these values were
expressed as the ratio of Treated to Control.STATISTICAL ANALYSISThe data obtained from treated samples were compared to corresponding
untreated groups from the same experiment as described above. In all
RT-qPCR experiments, aliquots of samples were analyzed in technical dupli-
cates or triplicates (n¼ 1); each reported value (unless stated otherwise) rep-
resents separate RNA isolations and RT reactions from at least two samples
(n 2) and analyzed as described above. For gene expression, the ratios of
Treated/Control samples were reported as the mean standard deviation.
The means among groups were compared by a one-way analysis of vari-
ance and the TukeyeKramer multiple comparison test for considerable
differences between groups using a graphing software package (Kaleida-
Graph 4.0, Synergy Software, Reading, PA); statistical signiﬁcance was con-
sidered to be P 0.05.ResultsRESPONSE OF ELECTRICALLY STIMULATED AGGRECAN AND
TYPE II COLLAGEN EXPRESSION TO SIGNAL TRANSDUCTION
INHIBITORSAdult bovine articular chondrocytes were cultured in mod-
iﬁed Cooper dishes and subjected to capacitive coupled
stimulation in the absence or presence of speciﬁc signal
transduction pathway inhibitors using the optimal signals
for aggrecan and type II collagen up-regulation as previ-
ously described10. The results (Fig. 3) show that: (1) in
the absence of inhibitors, electrical stimulation induces
a signiﬁcant 3e4-fold up-regulation of both aggrecan and
type II collagen mRNA; (2) the presence of inhibitors alone
does not affect aggrecan or type II collagen mRNA levels;
(3) inhibitors of intracellular calcium regulation and IP3 for-
mation (TMB-8 and neomycin, respectively) have no effect
on the up-regulation of mRNA levels by electrical stimula-
tion; and (4) inhibitors of voltage-gated calcium channels
(verapamil), calmodulin activation (W-7), calcineurin activity
(cyclosporin A), phospholipase C activity (BPB) and PGE2
synthesis (indomethacin) completely inhibit the up-regulat-
ing effects of electrical stimulation.RESPONSE OF METALLOPROTEINASES EXPRESSION TO
INTERLEUKINIn the absence of IL-1b treatment, metalloproteinase
mRNA levels in adult bovine articular chondrocytes were
near the lower limits of accurate detection by RT-qPCR
(see Figs. 4 and 5, None). However, in the presence of
10 ng/ml IL-1b, relative expression levels increased
Fig. 4. Effect of IL-1b and/or signal transduction inhibitors on the regulation of MMP mRNA levels by electrical stimulation. For the groups
labeled None, Neomycin, Verapamil and Cyclosporin, n¼ 12; for all other groups, n¼ 6. (A) MMP-1 expression. * denotes P< 0.0001,
NS¼ not signiﬁcant (P> 0.99); ** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.22); y denotes stimulated
groups not signiﬁcantly different from each other (P> 0.55). (B) MMP-3 expression. * denotes P< 0.0001, NS¼ not signiﬁcant (P> 0.99);
** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.47); y denotes stimulated groups not signiﬁcantly different
from each other (P> 0.12). (C) MMP-13 expression. * denotes P< 0.0001, NS¼ not signiﬁcant (P> 0.99); ** denotes unstimulated groups
not signiﬁcantly different from each other (P> 0.07); y denotes stimulated groups not signiﬁcantly different from each other (P> 0.89).
Fig. 3. Effect of signal transduction inhibitors on the regulation of aggrecan and type II collagen mRNA levels by electrical stimulation. For the
groups labeled None, Neomycin, Verapamil and Cyclosporin, n¼ 12; for all other groups, n¼ 6. (A) Aggrecan expression. * denotes
P< 0.0001, NS¼ not signiﬁcant (P> 0.99); ** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.69); y denotes
stimulated groups not signiﬁcantly different from each other (P¼ 0.24). (B) Type II collagen expression. * denotes P< 0.0001, NS¼ not sig-
niﬁcant (P¼ 1); ** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.99); y denotes stimulated groups not signif-
icantly different from each other (P> 0.10).
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Fig. 5. Effect of IL-1b and/or signal transduction inhibitors on the regulation of ADAMTS mRNA levels by electrical stimulation. For the groups
labeled None, Neomycin, Verapamil and Cyclosporin, n¼ 12; for all other groups, n¼ 6. (A) ADAMTS-4 expression. * denotes P< 0.0001,
NS¼ not signiﬁcant (P> 0.98); ** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.94); y denotes stimulated
groups not signiﬁcantly different from each other (P> 0.69). (B) ADAMTS-5 expression. * denotes P< 0.0001, NS¼ not signiﬁcant
(P> 0.91); ** denotes unstimulated groups not signiﬁcantly different from each other (P> 0.95); y denotes stimulated groups not signiﬁcantly
different from each other (P¼ 0.82).
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volving measurement of metalloproteinase mRNA levels
were performed in the presence of the cytokine.RESPONSE OF ELECTRICALLY STIMULATED MMP
EXPRESSION TO SIGNAL TRANSDUCTION INHIBITORSThe experimental protocol used was identical to that de-
scribed above for aggrecan and collagen except for the addi-
tion of IL-1b to the cultures. In the presence of interleukin, the
expression of MMP-1, -3 and -13 was then assessed in the
absence or presence of speciﬁc signal transduction pathway
inhibitors using the optimal signal for MMP down-regulationas previously described9. The results (Fig. 4) clearly show
that: (1) in the absence of inhibitors, electrical stimulation in-
duces a signiﬁcant 9.6, 7.1 or 8.6-fold down-regulation of
MMP-1, -3 and -13, respectively; (2) the presence of inhibi-
tors alone does not affect MMP mRNA levels; (3) inhibitors
of intracellular calcium regulation and IP3 formation (TMB-8
and neomycin, respectively) have no or little effect on the
down-regulation of MMP mRNA levels by electrical stimula-
tion; and (4) inhibitors of voltage-gated calcium channels (ve-
rapamil), calmodulin activation (W-7), calcineurin activity
(cyclosporin A), phospholipase C activity (BPB) and PGE2
synthesis (indomethacin) completely inhibit the down-regu-
lating effects of electrical stimulation.
Table I
Oligonucleotide primers used for qPCR of bovine metalloproteinases
Gene Genbank number Nucleotide sequence (50/ 30)* Amplicon size (bp) Efﬁciencyy (%)
MMP-1 X58256 50-CAAGATGTGGAGACGGTGAAGA-30 85 99
50-CGTTTCTCTGCCTTTCAACTTTC-30
MMP-3 AB043995 50-GGAAAACTCACCTCACGTACAGAA-30 86 100
50-CAGAGCTTTTTCAATGGCAGAAT-30
MMP-13 AF072685 50-GGATTCAGGGAAGACGCTCTT-30 88 98
50-TCTCGGGTAGTCTTTATCCATCACA-30
ADAMTS-4 AF192770 50-TGCGCCATTGTGGAGGAT-30 90 93
50-CGAGTTGTCATGGAGCATGCT-30
ADAMTS-5 AF192771 50-TCAGCCACCATCACAGAATTTC-30 76 100
50-CGGGAATCTGTTTTCGTGGTA-30
*Forward (sense) primer is listed ﬁrst.
yEfﬁciency of ampliﬁcation, calculated as described by Ginzinger67.
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EXPRESSION TO SIGNAL TRANSDUCTION INHIBITORSThe experimental protocol used was identical to that de-
scribed above for MMPs. The results (Fig. 5) clearly show
that: (1) in the absence of inhibitors, electrical stimulation in-
duces a signiﬁcant 3.7-fold down-regulation of ADAMTS-4
and -2 mRNA; (2) the presence of inhibitors does not affect
ADAMTS-5 mRNA levels; (3) inhibitors of intracellular cal-
cium regulation and IP3 formation (TMB-8 and neomycin,
respectively) have no or little effect on the down-regulation
of ADAMTS mRNA levels by electrical stimulation; and (4)
inhibitors of voltage-gated calcium channels (verapamil),
calmodulin activation (W-7), calcineurin activity (cyclosporin
A), phospholipase C activity (BPB) and PGE2 synthesis (in-
domethacin) completely inhibit the down-regulating effects
of electrical stimulation.Table II
Relative mRNA abundance of metalloproteinases (MPs) in adult
bovine articular chondrocytes in the absence or presence of IL-1b
Enzyme MP/GAPDH
(IL-1b)*
MP/GAPDH
(þIL-1b)*
Fold induction
MMP-1 0.0044 0.0021 1.78 0.92 398 36
MMP-3 0.0009 0.0005 0.26 0.14 305 35
MMP-13 0.0005 0.0004 0.34 0.26 676 102
ADAMTS-4 0.0005 0.0003 0.07 0.04 132 17
ADAMTS-5 0.0017 0.0012 0.12 0.08 68 2
*Cells were incubated for 24 h in the absence () or presence
(þ) of 10 ng/ml IL-1b and isolated total RNA was subjected to
RT-qPCR (n¼ 12). Relative values for MP mRNA levels were nor-
malized to GAPDH mRNA levels.Discussion
Articular cartilage chondrocytes in vitro respond to a vari-
ety of chemical and physical signals including electrici-
ty4,33e40. Recent studies from our laboratory have
investigated the effects of capacitively coupled electrical
stimulation on adult bovine articular chondrocytes in mass
culture and in cartilage explants10,11, and on human osteo-
arthritic cartilage explants9. We chose to use the mass cul-
ture format rather than cartilage explants primarily because
of our concern about the ability of the various metabolic in-
hibitors to quickly and effectively penetrate intact cartilage.
Our experiments showed that articular cartilage chondro-
cytes respond by increasing aggrecan and type II collagen
expression at both the transcriptional and translational
levels (in the absence or presence of IL-1b), and by de-
creasing IL-1b-induced metalloproteinase expression at
the transcription level (we have not yet measured metallo-
proteinase activity and/or protein levels). Notwithstanding
the above observations, however, the signal transduction
pathways by which capacitively coupled electrical stimula-
tion affects chondrocyte gene expression had not been pre-
viously elucidated.
A common cellular signaling pathway involves a Ca2þ/
calmodulin-dependent phosphatase (calcineurin) that is re-
sponsible for the dephosphorylation of the cytoplasmic form
of the transcription factor NF-AT. This results in the translo-
cation of NF-AT to the nucleus where it binds cooperatively
with other transcription factors to the regulatory regions ofinducible genes (see Fig. 2)41. In the experiments described
here, it was clearly shown that in adult bovine articular
chondrocytes in vitro, inhibitors of voltage-gated calcium
channels (verapamil), calmodulin activation (W-7), calci-
neurin activity (cyclosporin A), phospholipase C activity
(BPB) and PGE2 synthesis (indomethacin) completely block
both the electrically induced up-regulation of aggrecan and
type II collagen expression, and the down-regulation of IL-
1b-induced metalloproteinase expression. In contrast, inhib-
itors of intracellular calcium regulation and IP3 formation
(TMB-8 and neomycin, respectively) have no or little inﬂu-
ence on the above electrical effects. Thus, a ﬂux of calcium
via voltage-gated channels is implicated in transducing the
capacitively coupled electrical signal in these cells (see
Fig. 2). Indeed, it has recently been shown that a speciﬁc
inhibitor of the voltage-gated calcium channel reduced the
expression of MMP-1, -3 and -13 in osteoarthritic canine
chondrocytes18. This effect could be a result of reduced ac-
tivation of transcription factors (e.g., Elk-1 via protein kinase
C and the extracellular signal regulated protein kinase) nec-
essary for MMP transcription17. Since voltage-gated ion
channels are the key membrane proteins that mediate volt-
age-evoked cell signaling42, it should not be surprising that
they are implicated in electrical stimulation events. Also, the
role of Ca2þ as an intracellular messenger leading to gene
transcription is amply documented43. Nevertheless, it still
remains to be determined what are the subsequent down-
stream pathways ultimately leading to a direct regulation
of matrix and metalloproteinase expression at the transcrip-
tional level.
404 J. Xu et al.: Signal transduction in electrically stimulated chondrocytesAlthough it has been reported that 10 mM cyclosporin A
inhibited IL-1b-induced MMP-13 and ADAMTS-4 and
-5dbut not MMP-1 and -3dexpression44, whereas
0.8 mM inhibited MMP-1 and -3 and ADAMTS-4dbut not
MMP-13 and ADAMTS-5dexpression in chondrocytes45,
our data (Figs. 4 and 5) did not show any inhibitory effect
of 33 mM cyclosporin A alone on any of these enzymes.
The reason for these disparate results cannot yet be ex-
plained. Nevertheless, Little et al.44 found that preincuba-
tion of bovine articular chondrocytes with 10 mM
cyclosporin A did not inhibit NF-AT activation.
The observed effects of electrical stimulation on chondro-
cytesdup-regulation of matrix genes and down-regulation
of metalloproteinase genesdmay not operate directly
through the calcium-induced transcription pathway dis-
cussed above since NF-AT is usually involved in the up-reg-
ulation (not down-regulation) of gene transcription46. The
transcription results are, however, consistent with the ac-
tions of TGF-b, a multipotent regulator of extracellular ma-
trix production. Speciﬁcally, TGF-b has been shown to
impart a protective role in articular cartilage by counteract-
ing the effects of IL-147,48. Thus, it could be postulated
that the electrically induced intracellular calcium cascade
would result in the NF-AT-associated up-regulation of
TGF-b expression that would subsequently act on the chon-
drocyte in an autocrine/paracrine fashion to counteract the
IL-1b-induced down-regulation of aggrecan and type II col-
lagen, and up-regulation of metalloproteinases. It is relevant
to note that, at least in some cells, expression of TGF-
b1damong other cytokinesdis NF-AT-regulated49. Al-
though we have not yet tested for such a scenario in our
electrically stimulated chondrocyte cultures, it has been
shown by others that PEMF can up-regulate TGF-b in chon-
drogenic models in vitro50 and in vivo51,52, and that ultra-
sound-induced higher expression of collagen and
aggrecan in chondrocytes is also mediated via elevated
TGF-b1 expression53. In addition, our laboratory has shown
previously that capacitively coupled electrical stimulation of
bone cells induces TGF-b1 expression in vitro54. This could
explain the roles of calmodulin, calcineurin and NF-AT.
At the same time, our results showed that the presence of
BPB and indomethacin, compounds that ultimately control
PG synthesis, could also inhibit the effects of electrical stim-
ulation. Thus, whatever the transduction pathways may be,
it is apparent that the calmodulinecalcineurineNF-AT path-
way and the PLA2eCOXePG pathway must be co-depen-
dent. It is interesting to note that PGE2, for example, can
modulate IL-1b-induced matrix protein and MMP expression
in chondrocytes55,56.
It has also been shown that a number of cytokines, in-
cluding IL-4, IL-10 and IL-13, are considered anti-cata-
bolic/anti-inﬂammatory by functioning as down-regulators
of IL-1b and MMP expression and up-regulators of IL-1 re-
ceptor antagonist expression and PGE2 production among
other effects57e59. Therefore, in our proposed signaling
pathway, such molecules could participate in the anti-cata-
bolic events observed in the presence of electrical stimula-
tion, but these cytokines have not yet been shown to
possess the associated anabolic properties (e.g., up-regu-
lation of aggrecan and type II collagen) as TGF-b does.
Chondrocytes contain a number of other relevant signal-
ing pathwaysdin addition to those discussed abovedin-
cluding the non-canonical WNT60, nuclear factor-kappa B,
mitogen-activated protein kinase and Smad pathways61,62;
and several of these pathways have been implicated in ar-
thritic diseases63e66. It remains to be determined which of
these pathways, if any, directly participate in thetransduction of capacitively coupled electrical signals. Fu-
ture experiments will be directed toward this end.Conﬂict of interest
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